AKTX logo

Akari Therapeutics (AKTX) Current Liabilities

Annual Current Liabilities

$4.58 M
-$7.46 M-61.93%

31 December 2023

AKTX Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Liabilities

$9.43 M
+$649.00 K+7.39%

01 September 2024

AKTX Quarterly Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AKTX Current Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-61.9%-
3 y3 years-12.2%+180.9%
5 y5 years-6.8%+27.1%

AKTX Current Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-61.9%at lowat high+209.6%
5 y5 years-61.9%at low-15.2%+209.6%
alltimeall time-78.3%+291.3%-75.1%+936.0%

Akari Therapeutics Current Liabilities History

DateAnnualQuarterly
Sept 2024
-
$9.43 M(+7.4%)
June 2024
-
$8.78 M(+38.8%)
Mar 2024
-
$6.33 M(+38.0%)
Dec 2023
$4.58 M(-61.9%)
$4.58 M(-12.4%)
June 2023
-
$5.23 M(+71.8%)
Dec 2022
$12.04 M(+97.6%)
-
June 2022
-
$3.05 M(-44.9%)
Mar 2022
-
$5.52 M(-9.4%)
Dec 2021
$6.09 M(+16.7%)
$6.09 M(+81.6%)
Sept 2021
-
$3.36 M(+3.5%)
June 2021
-
$3.24 M(-16.9%)
Mar 2021
-
$3.90 M(-25.2%)
Dec 2020
$5.22 M(-19.3%)
$5.22 M(-40.9%)
Sept 2020
-
$8.84 M(-20.5%)
June 2020
-
$11.11 M(+36.3%)
Mar 2020
-
$8.15 M(+26.0%)
Dec 2019
$6.47 M(+31.6%)
$6.47 M(-12.8%)
Sept 2019
-
$7.42 M(+13.7%)
June 2019
-
$6.52 M(-14.0%)
Mar 2019
-
$7.59 M(+54.3%)
DateAnnualQuarterly
Dec 2018
$4.92 M(-58.5%)
$4.92 M(-20.0%)
Sept 2018
-
$6.15 M(-25.7%)
June 2018
-
$8.28 M(-8.8%)
Mar 2018
-
$9.08 M(-23.4%)
Dec 2017
$11.85 M(+1.1%)
$11.85 M(+27.0%)
Sept 2017
-
$9.33 M(+2.1%)
June 2017
-
$9.14 M(-35.0%)
Mar 2017
-
$14.06 M(+20.1%)
Dec 2016
$11.71 M(-44.5%)
$11.71 M(+6.7%)
Sept 2016
-
$10.97 M(-35.4%)
June 2016
-
$16.99 M(+2.7%)
Mar 2016
-
$16.55 M(-21.7%)
Dec 2015
$21.13 M(+1703.4%)
$21.13 M(-44.1%)
Sept 2015
-
$37.80 M(+3837.2%)
June 2015
-
$960.00 K(+5.5%)
Mar 2015
-
$910.00 K(-22.3%)
Dec 2014
$1.17 M(-4.8%)
$1.17 M
Dec 2013
$1.23 M(-68.0%)
-
Dec 2012
$3.85 M(+72.2%)
-
Dec 2011
$2.24 M
-

FAQ

  • What is Akari Therapeutics annual total current liabilities?
  • What is the all time high annual current liabilities for Akari Therapeutics?
  • What is Akari Therapeutics annual current liabilities year-on-year change?
  • What is Akari Therapeutics quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Akari Therapeutics?

What is Akari Therapeutics annual total current liabilities?

The current annual current liabilities of AKTX is $4.58 M

What is the all time high annual current liabilities for Akari Therapeutics?

Akari Therapeutics all-time high annual total current liabilities is $21.13 M

What is Akari Therapeutics annual current liabilities year-on-year change?

Over the past year, AKTX annual total current liabilities has changed by -$7.46 M (-61.93%)

What is Akari Therapeutics quarterly total current liabilities?

The current quarterly current liabilities of AKTX is $9.43 M

What is the all time high quarterly current liabilities for Akari Therapeutics?

Akari Therapeutics all-time high quarterly total current liabilities is $37.80 M